Anixa Biosciences announced developments regarding its CER-T cancer treatment, collaborating with Cleveland Clinic, at a conference in New York City on September 2, 2025.
2 reports, 1 independent
Updated Sep 2
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Anixa Biosciences announced developments regarding its CER-T cancer treatment, collaborating with Cleveland Clinic, at a conference in New York City on September 2, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Anixa Biosciences and Cleveland Clinic are developing a vaccine portfolio and ovarian cancer immunotherapy program.Sub-event
Anixa Biosciences details CER-T vaccine development with Cleveland Clinic at NYC conference.1 source
- Anixa announced a CAR-T clinical trial in San Jose, utilizing CER-T technology.
Keep exploring
The entities involved
-
Cleveland Clinic
nonprofit multispecialty academic medical center based in Cleveland, Ohio, United States
-
New York City
most populous city in the United States
-
Company
Direct Mail Division of FSSI
-
Amit Kumar
researcher (materials)
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- PR NewswireAnixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference SAN JOSE, Calif., Sept. 2, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anix
- Unknown outlet